Originally posted by rhinoceros
View Post
Unconfigured Ad
Collapse
X
-
I indeed named it oddly. Anyway, it produced results, but seems to be unreliable... The e value for 62-796337 is 1e-10 in the attached picture. So what's your suggestion for the e value cutoff?
-
Based on blastn (at ncbi) your sequence is not a tRNA. The 'best' hit is "PREDICTED: Dasypus novemcinctus WW domain-binding protein 4-like (LOC101430251), transcript variant 2, mRNA".
Perhaps consider a more conservative evalue cutoff? Also, how did you create your Rfam db? "-db Rfam.fasta" looks rather wrong to me but maybe you just named it oddly...
Leave a comment:
-
blast result against rfam database
Hi All,
I am blasting my miRNA-seq fasta file against rFam data base. Here is the command line I used:
blastn -query TOTAL_mapped_reads.fa -task megablast -db Rfam.fasta -out mapped_vs_rfam.txt -outfmt "6 qseqid sseqid qlen evalue pident nident mismatch qcovs qcovhsp"
Then I want to retrive those reads which match tRNAs in rFam.
There are many hits in the output (see the attached picture).
But when I pick the first read which is shown to be 100% match with rRNA in rfam by searching it in rfam website, there is no hit.
>62-796337
TCCCATATGGTCTAGCGGTTAGGATTCCTGGTT
Briefly, according to my blast result against rfam database, there is a match, but when I search the my sequence in online rfam website, there is no hit. So what is the problem?Attached FilesTags: None
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: